46 completed, 8 terminated, 8 unknown, 7 recruiting. 26 Not applicable, 22 Phase 2, 10 Phase 1, 6 Phase 3.
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Impact of AI on Prostate Cancer Workflow AI - Prostate Cancer, Prostatic Neoplasm | Not applicable | Recruiting | Case Comprehensive Cancer Center | 150 | 2025-09-09 | 2026-09-15 |
| PSMA PET Combined With MRI for the Detection of PCa 68Ga-PSMA-11 - PCA, Prostate Cancer | Phase 3 | Active not recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 338 | 2025-08-18 | 2026-10-20 |
| Dietary Fibre Supplementation to Delay Disease Progression in Early Prostate Cancer Qualitative semi-structured interviews, Focus group - Prostate Cancer, Prostatic Neoplasm | Completed | University of Aberdeen | 10 | 2024-07-03 | 2026-08-31 | |
| Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness Dietary recommendations, Time-restricted eating - Prostatic Neoplasm, Survivorship | Phase 1 / Phase 2 | Active not recruiting | University of Maryland, Baltimore | 30 | 2024-01-29 | 2026-01-27 |
| A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC AAA617, AAA517, Piflufolastat F 18 - Prostatic Neoplasm | Phase 2 | Active not recruiting | Novartis Pharmaceuticals | 49 | 2024-01-03 | 2026-10-21 |
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression observational study - Prostate Cancer, Prostate Adenocarcinoma | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 25 | 2023-03-20 | 2024-03-05 | |
| DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations Trastuzumab, Pertuzumab - Haematological Malignancy, Colorectal Neoplasms | Phase 2 / Phase 3 | Recruiting | Cancer Research UK | 30 | 2023-03-07 | 2025-12-02 |
| Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. Standard care - Prostatic Neoplasm, Adenocarcinoma | Not applicable | Recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 3000 | 2023-02-28 | 2025-11-17 |
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP salvage SBRT - Prostatic Neoplasm | Phase 2 | Unknown | Regina Elena Cancer Institute | 103 | 2022-09-27 | 2022-12-28 |
| A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting data collection - Prostatic Neoplasm | Unknown | Centre Hospitalier Universitaire de Besancon | 264 | 2022-04-05 | 2022-11-10 | |
| Impact of Augmented Reality During Robot-assisted Radical Prostatectomy Augmented reality robot-assited radical prostatectomy, Mixed reality intraoperative frozen section analysis, Robot-assited radical prostatectomy - Prostatic Neoplasm | Not applicable | Recruiting | European Institute of Oncology | 318 | 2022-01-01 | 2025-08-12 |
| EBRT + Lu-PSMA for N1M0 Prostate Cancer 177Lu-PSMA-617, EBRT - Prostatic Neoplasm | Phase 1 | Completed | The Netherlands Cancer Institute | 14 | 2021-12-20 | 2025-12-10 |
| 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical [68Ga]Ga-HTK03149 PET/CT - Prostate Cancer, Prostatic Neoplasm | Not applicable | Unknown | British Columbia Cancer Agency | 10 | 2021-08-30 | 2021-12-03 |
| Urinary and Prostate Microbiotes and Prostate Cancer prostate biopsy, Urinary sampling, Rectal swabbing before biopsies are performed - Prostatic Neoplasm | Not applicable | Completed | Centre Hospitalier Universitaire de Nice | 296 | 2021-02-04 | 2023-12-04 |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer 68Ga-PSMA-11 - Prostatic Neoplasm, Prostatic Cancer | Active not recruiting | British Columbia Cancer Agency | 1574 | 2021-02-01 | 2025-05-09 | |
| SLPI for Prostate Cancer Secretory leukocyte protease inhibitor (SLPI) in prostate cancer, Determination of molecular alterations, Secretory leukocyte protease inhibitor (SLPI) Healthy - Prostate Cancer, Prostatic Neoplasm | Unknown | University of Florence | 280 | 2020-12-01 | 2022-05-09 | |
| Trial of NanoPac Focal Therapy for Prostate Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Terminated | NanOlogy, LLC | 1 | 2020-10-20 | 2022-03-29 |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors AH-HA Tool in the EPIC EHR - Breast Neoplasm, Prostatic Neoplasm | Not applicable | Completed | Wake Forest University Health Sciences | 645 | 2020-10-01 | 2026-04-15 |
| Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed [68Ga]Ga-PSMA-11 PET/CT - Prostate Cancer, Prostatic Neoplasm | Not applicable | Unknown | Azienda Ospedaliero-Universitaria di Modena | 100 | 2020-09-20 | 2020-09-17 |
| The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy General Anaesthesia, Combined (Epidural and Spinal) Anaesthesia, Open Retropubic Radical Prostatectomy - Prostatic Neoplasm | Not applicable | Completed | Sismanoglio General Hospital | 60 | 2020-07-27 | 2022-10-04 |
Showing 20 of 74. Sign in to see all of them.
Prostatic Neoplasms (74) · Neoplasms (9) · Urogenital Neoplasms (7) · Prostatic Diseases (6) · Genital Neoplasms, Male (5) · Adenocarcinoma (3) · Breast Neoplasms (3) · Urinary Bladder Neoplasms (3) · Colorectal Neoplasms (2) · Disease Attributes (2) · Health Behavior (2) · Motor Activity (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Prostatic Neoplasms, Castration-Resistant (2)
Genital Diseases (74) · Male Urogenital Diseases (74) · Urogenital Diseases (74) · Genital Diseases, Male (73) · Neoplasms by Site (73) · Genital Neoplasms, Male (69) · Prostatic Diseases (68) · Urogenital Neoplasms (67) · Neoplasms (65) · Pathological Conditions, Signs and Symptoms (12) · Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Pathologic Processes (7) · Neoplasms by Histologic Type (5) · Digestive System Diseases (4)
Multiparametric Magnetic Resonance Imaging (3) · gallium 68 PSMA-11 (3) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (2) · Leuprolide (2) · Pluvicto (2) · Radiotherapy (2) · Standard of Care (2) · 18F-JK-PSMA-7 (1) · 5'-ACCaagtttcttcAGC-3' (1) · 7-hydroxystaurosporine (1) · Abiraterone Acetate (1) · Androgen Antagonists (1) · Anesthesia (1) · Anesthesia, General (1) · Blood Specimen Collection (1)
National Cancer Institute (NCI) (4) · British Columbia Cancer Agency (3) · AHS Cancer Control Alberta (2) · Fondazione del Piemonte per l'Oncologia (2) · Michael Graham PhD, MD (2) · Novartis Pharmaceuticals (2) · Regina Elena Cancer Institute (2) · Seoul National University Hospital (2) · University Health Network, Toronto (2) · ATGen Canada Inc (1) · Abbott (1) · Advanced Accelerator Applications (1) · Aurelius Omlin (1) · Azienda Ospedaliero-Universitaria di Modena (1) · Azienda USL Reggio Emilia - IRCCS (1)
United States (30) · Canada (12) · Italy (12) · France (6) · South Korea (5) · Spain (4) · United Kingdom (4) · Australia (3) · Belgium (3) · Netherlands (3) · Brazil (2) · Czechia (2) · Germany (2) · Poland (2) · Chile (1)
Francois Benard, MD (2) · Aby Buchbinder, MD (1) · Alfonso Gomez-Iturriaga, MD, PhD (1) · Amber Kleckner, PhD (1) · Andrei Purysko, MD (1) · Andrew Bayley, MD (1) · Athanasios Papatsoris, Prof. (1) · Aurelius G Omlin, MD (1) · B. Simon Rosser, PhD (1) · Corinne Joshu, PhD (1) · Daniel Danila, MD (1) · Darpan Patel, PhD (1)
PMID 10411052, PMID 11251539, PMID 12187196, PMID 15538237, PMID 16879671, PMID 18399830, PMID 18423693, PMID 18480623, PMID 19185977, PMID 19281468, PMID 19836778, PMID 19888782, PMID 19931979, PMID 19944519, PMID 20141676, PMID 20514284, PMID 20633003, PMID 20643426, PMID 20952022, PMID 21103791, PMID 21106711, PMID 22749850, PMID 22749851, PMID 22749852, PMID 22749853, PMID 22763081, PMID 23253772, PMID 23356390, PMID 25194450, PMID 29722851, PMID 31062066, PMID 33893066, PMID 34348045, PMID 35194723, PMID 36959540, PMID 37224793, PMID 38297229, PMID 38428681, PMID 38453598, PMID 39571113, PMID 39606939, PMID 39854647, PMID 40506027, PMID 41748290, PMID 42570448, PMID 7120554, PMID 7523730
2017 (1), 2019 (1), R01CA218657 (1), R01CA226078 (1), R21CA202214 (1)